Cutaneous Leishmaniasis after Travel to Cyprus and Successful Treatment with Miltefosine

Wolfgang Poeppl Department of Dermatology and Tropical Medicine, Military Hospital Vienna, Austria; Institute of Specific Prophylaxis and Tropical Medicine, Department of Medical Parasitology, Medical University of Vienna, Vienna, Austria

Search for other papers by Wolfgang Poeppl in
Current site
Google Scholar
PubMed
Close
,
Julia Walochnik Department of Dermatology and Tropical Medicine, Military Hospital Vienna, Austria; Institute of Specific Prophylaxis and Tropical Medicine, Department of Medical Parasitology, Medical University of Vienna, Vienna, Austria

Search for other papers by Julia Walochnik in
Current site
Google Scholar
PubMed
Close
,
Tom Pustelnik Department of Dermatology and Tropical Medicine, Military Hospital Vienna, Austria; Institute of Specific Prophylaxis and Tropical Medicine, Department of Medical Parasitology, Medical University of Vienna, Vienna, Austria

Search for other papers by Tom Pustelnik in
Current site
Google Scholar
PubMed
Close
,
Herbert Auer Department of Dermatology and Tropical Medicine, Military Hospital Vienna, Austria; Institute of Specific Prophylaxis and Tropical Medicine, Department of Medical Parasitology, Medical University of Vienna, Vienna, Austria

Search for other papers by Herbert Auer in
Current site
Google Scholar
PubMed
Close
, and
Gerhard Mooseder Department of Dermatology and Tropical Medicine, Military Hospital Vienna, Austria; Institute of Specific Prophylaxis and Tropical Medicine, Department of Medical Parasitology, Medical University of Vienna, Vienna, Austria

Search for other papers by Gerhard Mooseder in
Current site
Google Scholar
PubMed
Close
Restricted access

A patient presenting with an atypical manifestation of cutaneous leishmaniasis after travel to Cyprus was successfully treated with miltefosine. The K26 typing revealed a hitherto undescribed strain of the Leishmania donovani/infantum complex as the causing agent.

Author Notes

*Address correspondence to Wolfgang Poeppl, Department of Dermatology, Military Hospital Vienna, Brünnerstraße 238, 1210 Vienna, Austria. E-mail: wolfgang.poeppl@meduniwien.ac.at

Authors' addresses: Wolfgang Poeppl, Tom Pustelnik, and Gerhard Mooseder, Department of Dermatology, Military Hospital Vienna, Vienna, Austria, E-mails: wolfgang.poeppl@meduniwien.ac.at, tom@hautarztpustelnik.at, and gmoos@gmx.at. Julia Walochnik and Herbert Auer, Institute of Specific Prophylaxis and Tropical Medicine, Department of Medical Parasitology, Medical University of Vienna, Vienna, Austria, E-mails: julia.walochnik@meduniwien.ac.at and herbert.auer@meduniwien.ac.at.

  • 1.

    Reithinger R, Dujardin JC, Louzir H, Pirmez C, Alexander B, Brooker S, 2007. Cutaneous leishmaniasis. Lancet Infect Dis 7: 581596.

  • 2.

    Gonzalez U, Pinart M, Reveiz L, Alvar J, 2008. Interventions for Old World cutaneous leishmaniasis. Cochrane Database Syst Rev CD005067.

  • 3.

    Blum J, Desjeux P, Schwartz E, Beck B, Hatz C, 2004. Treatment of cutaneous leishmaniasis among travellers. J Antimicrob Chemother 53: 158166.

  • 4.

    Mondal S, Bhattacharya P, Ali N, 2010. Current diagnosis and treatment of visceral leishmaniasis. Expert Rev Anti Infect Ther 8: 919944.

  • 5.

    Calvopina M, Gomez EA, Sindermann H, Cooper PJ, Hashiguchi Y, 2006. Relapse of new world diffuse cutaneous leishmaniasis caused by Leishmania (Leishmania) mexicana after miltefosine treatment. Am J Trop Med Hyg 75: 10741077.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 6.

    Mohebali M, Fotouhi A, Hooshmand B, Zarei Z, Akhoundi B, Rahnema A, Razaghian AR, Kabir MJ, Nadim A, 2007. Comparison of miltefosine and meglumine antimoniate for the treatment of zoonotic cutaneous leishmaniasis (ZCL) by a randomized clinical trial in Iran. Acta Trop 103: 3340.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 7.

    Soto J, Toledo JT, 2007. Oral miltefosine to treat new world cutaneous leishmaniasis. Lancet Infect Dis 7: 7.

  • 8.

    Tappe D, Muller A, Stich A, 2010. Resolution of cutaneous old world and new world leishmaniasis after oral miltefosine treatment. Am J Trop Med Hyg 82: 13.

  • 9.

    Faber WR, Wonders J, Jensema AJ, Chocholova E, Kager PA, 2009. Cutaneous leishmaniasis with lymphadenopathy due to Leishmania donovani. Clin Exp Dermatol 34: e196e198.

  • 10.

    Neub A, Krahl D, Stich A, Amon U, 2008. Cutaneous infection with Leishmania infantum in an infant treated successfully with miltefosine. J Dtsch Dermatol Ges 6: 10611064.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 11.

    van Eys GJ, Schoone GJ, Kroon NC, Ebeling SB, 1992. Sequence analysis of small subunit ribosomal RNA genes and its use for detection and identification of Leishmania parasites. Mol Biochem Parasitol 51: 133142.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 12.

    Dujardin JC, Campino L, Canavate C, Dedet JP, Gradoni L, Soteriadou K, Mazeris A, Ozbel Y, Boelaert M, 2008. Spread of vector-borne diseases and neglect of leishmaniasis, Europe. Emerg Infect Dis 14: 10131018.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 13.

    Haralambous C, Antoniou M, Pratlong F, Dedet JP, Soteriadou K, 2008. Development of a molecular assay specific for the Leishmania donovani complex that discriminates L. donovani/Leishmania infantum zymodemes: a useful tool for typing MON-1. Diagn Microbiol Infect Dis 60: 3342.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 14.

    Nicholas KB, Nicholas HB Jr., Deerfield DW II, 1997. GeneDoc: analysis and visualization of genetic variation. Embnet News 4: 14.

  • 15.

    Antinori S, Gianelli E, Calattini S, Longhi E, Gramiccia M, Corbellino M, 2005. Cutaneous leishmaniasis: an increasing threat for travellers. Clin Microbiol Infect 11: 343346.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 16.

    Alam MZ, Haralambous C, Kuhls K, Gouzelou E, Sgouras D, Soteriadou K, Schnur L, Pratlong F, Schonian G, 2009. The paraphyletic composition of Leishmania donovani zymodeme MON-37 revealed by multilocus microsatellite typing. Microbes Infect 11: 707715.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 17.

    Mazeris A, Soteriadou K, Dedet JP, Haralambous C, Tsatsaris A, Moschandreas J, Messaritakis I, Christodoulou V, Papadopoulos B, Ivovic V, Pratlong F, Loucaides F, Antoniou M, 2010. Leishmaniases and the Cyprus paradox. Am J Trop Med Hyg 82: 441448.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 18.

    Antoniou M, Haralambous C, Mazeris A, Pratlong F, Dedet JP, Soteriadou K, 2008. Leishmania donovani leishmaniasis in Cyprus. Lancet Infect Dis 8: 67.

Past two years Past Year Past 30 Days
Abstract Views 52 41 4
Full Text Views 357 8 2
PDF Downloads 71 6 4
 
 
 
 
Affiliate Membership Banner
 
 
Research for Health Information Banner
 
 
CLOCKSS
 
 
 
Society Publishers Coalition Banner
Save